CCR1 and neoplasm: Given the inverse relationship between CCL23 and CXCL10 in human ovarian ascites samples and reduced survival in patients with low tumor CXCL10 expression, we hypothesized that the activation of CCR1 via CCL23 impairs CXCL10 secretion from myeloid cells.